Imatinib for systemic mast-cell disease

This publication has 5 references indexed in Scilit:

• Evidence for the involvement of a hematopoietic progenitor cell in systemic mastocytosis from single-cell analysis of mutations in the c-kit gene
  Blood, 2002
• Treatment of hypereosinophilic syndrome with imatinib mesilate
  The Lancet, 2002
• The c-KIT mutation causing human mastocytosis is resistant to STI571 and other KIT kinase inhibitors; kinases with enzymatic site mutations show different inhibitor sensitivity profiles than wild-type kinases and those with regulatory-type mutations
  Blood, 2002
• Inhibition of c-kit receptor tyrosine kinase activity by STI 571, a selective tyrosine kinase inhibitor
  Blood, 2000
• Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product.
  Journal of Clinical Investigation, 1993